Financial statements Vademecum Pharma
Balance sheet of Vademecum Pharma
Company age:
Age:
16 y. 2 m. 16 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of VADEMECUM PHARMA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 235 487,92 | 235 487,92 | 235 487,92 |
| A. Fixed assets | 234 083,33 | 234 083,33 | 234 083,33 |
| B. Current assets | 1 404,59 | 1 404,59 | 1 404,59 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | - |
| Total liabilities | 235 487,92 | 235 487,92 | 235 487,92 |
| A. Equity | 209 287,39 | 209 287,39 | 209 287,39 |
| B. Liabilities and provisions for liabilities | 26 200,53 | 26 200,53 | 26 200,53 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.